Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Thiadiazole STAT6 activation inhibitors designed at Sumitomo

Oct. 26, 2000

Novel immunosuppressants revealed by Japanese lab

Oct. 26, 2000

SmithKline Beecham's combination pediatric vaccine approved in E.U.

Oct. 26, 2000

Phase II trial with EBV vaccine begins, triggering milestone payment to Aviron

Oct. 26, 2000

Ariad receives GVHD treatment patent

Oct. 25, 2000

NIH grant to support Avant's herpes vaccine development

Oct. 25, 2000

Repligen's soluble form of CTLA4 cleared for phase II trials

Oct. 25, 2000

Meningococcal C meningitis vaccine approved for very young infants

Oct. 19, 2000

NIH awards Siga grant for vaccine research

Oct. 19, 2000

U.K. researchers patent glycopeptides that enhance T-cell proliferation

Oct. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...